Multi‐omic analysis in carcinoma of unknown primary ( <scp>CUP</scp> ): therapeutic impact of knowing the unknown-Reference-Cited by-同舟云学术

Multi‐omic analysis in carcinoma of unknown primary ( CUP ): therapeutic impact of knowing the unknown

Published:2022-07-22 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Kato Shumei¹^ORCID,Gumas Sophia¹,Adashek Jacob J.²,Okamura Ryosuke³,Lee Suzanna¹,Sicklick Jason K.¹⁴,Kurzrock Razelle¹

Affiliation:

1. Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center La Jolla CA USA

2. Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital Baltimore MD USA

3. Department of Surgery Kyoto University Hospital Kyoto Japan

4. Department of Surgery, Division of Surgical Oncology UC San Diego School of Medicine San Diego CA USA

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13293

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design;Cancer Treatment Reviews;2024-04

2. Advances in Cancer Research: Current and Future Diagnostic and Therapeutic Strategies;Biosensors;2024-02-16

3. Pelvic squamous cell carcinoma of unknown primary origin with hydronephrosis and ureteral stricture: A case report;Medicine;2024-01-26

4. Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics;Pharmaceuticals;2023-04-19

5. Immunochemotherapy achieved a complete response for metastatic adenocarcinoma of unknown primary based on gene expression profiling: a case report and review of the literature;Frontiers in Immunology;2023-04-19